PRELOAD PRELOAD PRELOAD PRELOAD PRELOAD

Products

Products

BioMarin has developed and commercialized three products in ten years, a remarkable accomplishment in the biopharmaceutical industry, and a testament to the company’s passion and dedication to patients with serious, unmet medical needs.

Products on the Market

BioMarin has three approved products on the market today:
  • Kuvan® (sapropterin dihydrochloride) Tablets for PKU
  • Naglazyme® (galsulfase) for MPS VI
  • Aldurazyme® (laronidase) for MPS I

For full prescribing information, please visit www.kuvan.com, www.naglazyme.com, and www.aldurazyme.com.